Kaleido Biosciences Pink Sheet Forecast - Naive Prediction
| KLDO Stock | USD 0.0001 0.00 0.00% |
Kaleido Pink Sheet outlook is based on your current time horizon.
As of today, the relative strength index (RSI) of Kaleido Biosciences' share price is approaching 49. This indicates that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Kaleido Biosciences, making its price go up or down. Momentum 49
Impartial
Oversold | Overbought |
Using Kaleido Biosciences hype-based prediction, you can estimate the value of Kaleido Biosciences from the perspective of Kaleido Biosciences response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Kaleido Biosciences on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.0002 and the sum of the absolute errors of 0.01. Kaleido Biosciences after-hype prediction price | USD 9.8E-5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Kaleido |
Kaleido Biosciences Additional Predictive Modules
Most predictive techniques to examine Kaleido price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kaleido using various technical indicators. When you analyze Kaleido charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Kaleido Biosciences Naive Prediction Price Forecast For the 29th of January
Given 90 days horizon, the Naive Prediction forecasted value of Kaleido Biosciences on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0.0002, mean absolute percentage error of 0.00000039, and the sum of the absolute errors of 0.01.Please note that although there have been many attempts to predict Kaleido Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Kaleido Biosciences' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Kaleido Biosciences Pink Sheet Forecast Pattern
| Backtest Kaleido Biosciences | Kaleido Biosciences Price Prediction | Buy or Sell Advice |
Kaleido Biosciences Forecasted Value
In the context of forecasting Kaleido Biosciences' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Kaleido Biosciences' downside and upside margins for the forecasting period are 0.000001 and 222.01, respectively. We have considered Kaleido Biosciences' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Kaleido Biosciences pink sheet data series using in forecasting. Note that when a statistical model is used to represent Kaleido Biosciences pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 103.3469 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 2.0E-4 |
| MAPE | Mean absolute percentage error | 9.223372036854776E14 |
| SAE | Sum of the absolute errors | 0.0096 |
Predictive Modules for Kaleido Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kaleido Biosciences. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kaleido Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Kaleido Biosciences After-Hype Price Density Analysis
As far as predicting the price of Kaleido Biosciences at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kaleido Biosciences or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Kaleido Biosciences, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Kaleido Biosciences Estimiated After-Hype Price Volatility
In the context of predicting Kaleido Biosciences' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kaleido Biosciences' historical news coverage. Kaleido Biosciences' after-hype downside and upside margins for the prediction period are 0.00 and 50.01, respectively. We have considered Kaleido Biosciences' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Kaleido Biosciences is out of control at this time. Analysis and calculation of next after-hype price of Kaleido Biosciences is based on 3 months time horizon.
Kaleido Biosciences Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Kaleido Biosciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kaleido Biosciences backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kaleido Biosciences, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
45.03 | 222.01 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0001 | 0.000098 | 2.17 |
|
Kaleido Biosciences Hype Timeline
Kaleido Biosciences is now traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Kaleido is forecasted to decline in value after the next headline, with the price expected to drop to 9.8E-5. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -2.17%, whereas the daily expected return is now at 45.03%. The volatility of related hype on Kaleido Biosciences is about 0.0%, with the expected price after the next announcement by competition of 0.00. The company has price-to-book ratio of 0.0. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Kaleido Biosciences recorded a loss per share of 2.16. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out Historical Fundamental Analysis of Kaleido Biosciences to cross-verify your projections.Kaleido Biosciences Related Hype Analysis
Having access to credible news sources related to Kaleido Biosciences' direct competition is more important than ever and may enhance your ability to predict Kaleido Biosciences' future price movements. Getting to know how Kaleido Biosciences' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kaleido Biosciences may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BXRXQ | Baudax Bio | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TNGNQ | Tengion | 0.00 | 5 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IVBT | Innovation1 Biotech | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| XENO | Xeno Transplants | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SNNAQ | Sienna Biopharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CALA | Calithera Biosciences | 0.00 | 0 per month | 20.36 | 0.18 | 100.00 | (50.00) | 480.00 | |
| VIVE | Viveve Medical | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 877.78 | |
| TLOG | TetraLogic Pharmaceuticals Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BTTX | Better Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ARNI | Arno Therapeutics | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 100.00 |
Other Forecasting Options for Kaleido Biosciences
For every potential investor in Kaleido, whether a beginner or expert, Kaleido Biosciences' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kaleido Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kaleido. Basic forecasting techniques help filter out the noise by identifying Kaleido Biosciences' price trends.Kaleido Biosciences Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kaleido Biosciences pink sheet to make a market-neutral strategy. Peer analysis of Kaleido Biosciences could also be used in its relative valuation, which is a method of valuing Kaleido Biosciences by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Kaleido Biosciences Market Strength Events
Market strength indicators help investors to evaluate how Kaleido Biosciences pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kaleido Biosciences shares will generate the highest return on investment. By undertsting and applying Kaleido Biosciences pink sheet market strength indicators, traders can identify Kaleido Biosciences entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 | |||
| Relative Strength Index | 49.02 |
Kaleido Biosciences Risk Indicators
The analysis of Kaleido Biosciences' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kaleido Biosciences' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kaleido pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 229.45 | |||
| Standard Deviation | 697.11 | |||
| Variance | 485958.59 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Kaleido Biosciences
The number of cover stories for Kaleido Biosciences depends on current market conditions and Kaleido Biosciences' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kaleido Biosciences is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kaleido Biosciences' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Kaleido Biosciences Short Properties
Kaleido Biosciences' future price predictability will typically decrease when Kaleido Biosciences' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kaleido Biosciences often depends not only on the future outlook of the potential Kaleido Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kaleido Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 33.5 M | |
| Cash And Short Term Investments | 38.5 M |
Other Information on Investing in Kaleido Pink Sheet
Kaleido Biosciences financial ratios help investors to determine whether Kaleido Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kaleido with respect to the benefits of owning Kaleido Biosciences security.